INSERM U-901 Marseille, France.
Front Cell Neurosci. 2011 Jul 28;5:16. doi: 10.3389/fncel.2011.00016. eCollection 2011.
Diazepam (DZP) and phenobarbital (PB) are extensively used as first and second line drugs to treat acute seizures in neonates and their actions are thought to be mediated by increasing the actions of GABAergic signals. Yet, their efficacy is variable with occasional failure or even aggravation of recurrent seizures questioning whether other mechanisms are not involved in their actions. We have now compared the effects of DZP and PB on ictal-like events (ILEs) in an in vitro model of mirror focus (MF). Using the three-compartment chamber with the two immature hippocampi and their commissural fibers placed in three different compartments, kainate was applied to one hippocampus and PB or DZP to the contralateral one, either after one ILE, or after many recurrent ILEs that produce an epileptogenic MF. We report that in contrast to PB, DZP aggravated propagating ILEs from the start, and did not prevent the formation of MF. PB reduced and DZP increased the network driven giant depolarizing potentials suggesting that PB may exert additional actions that are not mediated by GABA signaling. In keeping with this, PB but not DZP reduced field potentials recorded in the presence of GABA and NMDA receptor antagonists. These effects are mediated by a direct action on AMPA/kainate receptors since PB: (i) reduced AMPA/kainate receptor mediated currents induced by focal applications of glutamate; (ii) reduced the amplitude and the frequency of AMPA but not NMDA receptor mediated miniature excitatory postsynaptic currents (EPSCs); (iii) augmented the number of AMPA receptor mediated EPSCs failures evoked by minimal stimulation. These effects persisted in MF. Therefore, PB exerts its anticonvulsive actions partly by reducing AMPA/kainate receptors mediated EPSCs in addition to the pro-GABA effects. We suggest that PB may have advantage over DZP in the treatment of initial neonatal seizures since the additional reduction of glutamate receptors mediated signals may reduce the severity of neonatal seizures.
地西泮(DZP)和苯巴比妥(PB)被广泛用作治疗新生儿急性发作的一线和二线药物,其作用被认为是通过增加 GABA 能信号的作用来介导的。然而,它们的疗效是可变的,偶尔会失败,甚至会加重反复发作的癫痫发作,这质疑它们的作用是否不涉及其他机制。我们现在比较了 DZP 和 PB 在镜像焦点(MF)的体外模型中对癫痫样事件(ILE)的影响。使用具有两个未成熟海马体及其连合纤维放置在三个不同隔室的三室室,向一个海马体施加海人酸,然后在一个 ILE 后或在产生致痫性 MF 的许多复发性 ILE 后,将 PB 或 DZP 施加到对侧海马体。我们报告说,与 PB 相反,DZP 从一开始就加重了传播性 ILE,并且不能防止 MF 的形成。PB 减少而 DZP 增加网络驱动的巨大去极化电位,表明 PB 可能发挥额外的作用,这些作用不是由 GABA 信号介导的。与此一致的是,PB 而不是 DZP 减少了在 GABA 和 NMDA 受体拮抗剂存在下记录的场电位。这些作用是通过对 AMPA/kainate 受体的直接作用介导的,因为 PB:(i)减少了由焦点应用谷氨酸诱导的 AMPA/kainate 受体介导的电流;(ii)减少了 AMPA 但不是 NMDA 受体介导的微小兴奋性突触后电流(EPSC)的幅度和频率;(iii)增加了最小刺激诱发的 AMPA 受体介导的 EPSC 失败的数量。这些作用在 MF 中仍然存在。因此,PB 通过除了 GABA 促进作用之外,还通过减少 AMPA/kainate 受体介导的 EPSC 来发挥其抗惊厥作用。我们建议,由于额外减少谷氨酸受体介导的信号,PB 在治疗新生儿初始癫痫发作方面可能优于 DZP,因为它可能减轻新生儿癫痫发作的严重程度。